Recruiting

Suicide Prevention

Sponsor:

The Hospital for Sick Children

Code:

NCT03488602

Conditions

Suicide

Suicide, Attempted

Suicidal Ideation

Eligibility Criteria

Sex: All

Age: 12 - 18

Healthy Volunteers: Not accepted

Interventions

F-SPS+UC

EUC

Study Details

Brief summary:

This study evaluates whether a Family-centered suicide prevention strategy, when added to usual care (F-SPS + UC), is more effective than enhanced usual care (EUC) in reducing suicide-related behaviors in 128 youth at high-risk of suicide. Half of the participants will be randomized to receive F-SPS + UC and half will receive EUC.

Conditions

Suicide

Suicide, Attempted

Suicidal Ideation

Study ID

NCT03488602

Start date

Mar 1, 2018

Status verified date

Mar, 2018

Completion date

Jul, 2020

Anticipated

Primary completion date

Feb, 2020

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 12 - 18

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Ages 12 to18 years
  • Youth presenting in the Emergency Department with acute suicidal ideation or suicide risk behaviour
  • SIQ-Jr score ≥ 31
  • Parent or caregiver able to communicate in English, or is willing to communicate using a hospital-organized translator, and willing to participate in study
  • Living in the greater Toronto area and access to a telephone.

Exclusion Criteria:

  • Active psychosis or hypomania/mania
  • Moderate to severe intellectual disability, autism.

Study Design

Enrollment

128 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: F-SPS Intervention

This group will receive the F-SPS intervention.

active comparator: Enhanced Usual Care (EUC)

This group will receive Enhanced Usual Care (EUC)

Interventions

F-SPS+UC

Manualized individual and family program. Weekly individual and family sessions with a therapist for 6 weeks.

Participants will continue to receive usual care.

EUC

Weekly telephone contact with parents regarding participant health care utilization. Referrals to community mental health resources provided as needed.

Participants will continue to receive usual care.

Primary outcome measure

  • Change in suicidal ideation severity as measured by the Suicidal Ideation Questionnaire - Jr [ Time Frame: Screening, 6 weeks, 24 weeks ]

Central Contacts and Locations

Central contacts

Matthew Tracey, MA

4165358501matthew.tracey@sickkids.ca

Reva Schachter, MSc

4165358501reva.schachter@sickkids.ca

Locations

Matthew Tracey

Recruiting

Toronto, Ontario, Canada, M5G 1X8

Contacts

Matthew Tracey, MA

4165358501matthew.tracey@sickkids.ca

Reva Schachter, MSc

4165358501reva.schachter@sickkids.ca

Principal Investigator:

Daphne J Korczak, MD, Msc

More Information

Sponsor

The Hospital for Sick Children

Last update posted

Apr 5, 2018

Last verified

Mar, 2018

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The Hospital for Sick Children on 2018-04-05.